Brazyn Life is a travel-friendly foam roller. Nate Lawrie and Tom Hopkins founded Brazyn Life in 2015. As of September 2023, Brazyn Life’s net worth is $4.8 million. Furthermore, they’re pulling in a whopping $6 million in annual revenue.
In October 2017, they appeared on Season 9 of Shark Tank USA and made a deal with Lori Greiner and Sara Blakely for $250,000 for 20% of equity. The final valuation was $1 million, down from the founder’s initial estimate of $2.25 million.
Brazyn Life Net Worth
|Net worth||$4.8 million (2023)|
|Annual Sales Revenue||$6 million (2023)|
|Investor||Lori Greiner and Sara Blakely|
|Founder||Nate Lawrie and Tom Hopkins|
Brazyn Life Net Worth Timeline
|Net Worth 2023||$4.8 million|
|Net Worth 2022||$4.8 million|
|Net Worth 2021||–|
|Net Worth 2020||–|
|Net worth valuation in 2017 after appearing on Shark Tank||$1.25 million|
|Net worth valuation in 2017 before appearing on Shark Tank||$2.25 million|
Brazyn Life Pitch on Shark Tank
|Company name||Brazyn Life|
|Product||Travel-friendly foam roller|
|Episode||Season 09 Episode 06|
|Founders||Nate Lawrie and Tom Hopkins|
|Asked for||$225,000 for 10% Equity|
|Final deal||$250,000 for 20% Equity|
|Sharks||Lori Greiner and Sara Blakely|
Don’t miss these product from Season 9
Brazyn Life Founders
Brazyn Life was founded by Nate Lawrie and Tom Hopkins in 2015. Nate, the CEO of the company, is a former NFL player. He is a well-known athlete and a dynamic entrepreneur. He also has an academic background in Political science. The co-founder and operations manager, Tom Hopkins, is also a skilled entrepreneur as well as a songwriter. Brazyn Life’s founders, Nate Lawrie and Tom Hopkins, have a net worth of 4.8 million USD as of 2023.
|2017||Shark Tank pitch|
|2018-2023||Positive feedback from customers and fitness experts|
From their beginnings on Shark Tank to their current status as a thriving business, they have proven that with the right idea and execution, anything is possible. We can’t wait to see the future for Brazyn Life and its continued success.